MXPA06008942A - Inmunoglobulinas anti-moleculas de adhesion a celulas epiteliales(epcam). - Google Patents

Inmunoglobulinas anti-moleculas de adhesion a celulas epiteliales(epcam).

Info

Publication number
MXPA06008942A
MXPA06008942A MXPA06008942A MXPA06008942A MXPA06008942A MX PA06008942 A MXPA06008942 A MX PA06008942A MX PA06008942 A MXPA06008942 A MX PA06008942A MX PA06008942 A MXPA06008942 A MX PA06008942A MX PA06008942 A MXPA06008942 A MX PA06008942A
Authority
MX
Mexico
Prior art keywords
cancer
immunoglobulin
epcam
administration
days
Prior art date
Application number
MXPA06008942A
Other languages
English (en)
Spanish (es)
Inventor
Malte Peters
Mathias Locher
Nadja Prang
Cornelia Quadt
Original Assignee
Micromet Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micromet Ag filed Critical Micromet Ag
Publication of MXPA06008942A publication Critical patent/MXPA06008942A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MXPA06008942A 2004-02-13 2005-02-09 Inmunoglobulinas anti-moleculas de adhesion a celulas epiteliales(epcam). MXPA06008942A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/778,915 US20050180979A1 (en) 2004-02-13 2004-02-13 Anti-EpCAM immunoglobulins
PCT/EP2005/001307 WO2005080428A2 (en) 2004-02-13 2005-02-09 Anti-epcam immunoglobulins

Publications (1)

Publication Number Publication Date
MXPA06008942A true MXPA06008942A (es) 2007-01-26

Family

ID=34838270

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06008942A MXPA06008942A (es) 2004-02-13 2005-02-09 Inmunoglobulinas anti-moleculas de adhesion a celulas epiteliales(epcam).

Country Status (23)

Country Link
US (3) US20050180979A1 (https=)
EP (2) EP2107071A3 (https=)
JP (1) JP5220315B2 (https=)
KR (1) KR101236224B1 (https=)
CN (1) CN1976951B (https=)
AT (1) ATE437186T1 (https=)
AU (1) AU2005215874B2 (https=)
BR (1) BRPI0507660A (https=)
CA (1) CA2555694C (https=)
DE (1) DE602005015544D1 (https=)
DK (1) DK1713830T3 (https=)
EA (1) EA011951B1 (https=)
ES (1) ES2328159T3 (https=)
IL (1) IL177069A (https=)
MX (1) MXPA06008942A (https=)
NO (1) NO339364B1 (https=)
NZ (1) NZ549125A (https=)
PL (1) PL1713830T3 (https=)
PT (1) PT1713830E (https=)
SI (1) SI1713830T1 (https=)
UA (1) UA87128C2 (https=)
WO (1) WO2005080428A2 (https=)
ZA (1) ZA200606083B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004068110A2 (en) 2003-01-24 2004-08-12 University Of Utah Methods of predicting mortality risk by determining telomere length
WO2007008943A2 (en) 2005-07-08 2007-01-18 Xencor, Inc. Optimized anti-ep-cam antibodies
CA2638040A1 (en) * 2006-02-09 2007-08-16 Micromet Ag Treatment of metastatic breast cancer
EP1865001A1 (en) * 2006-06-08 2007-12-12 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Specific protease inhibitors and their use in cancer therapy
ATE509956T1 (de) * 2006-06-08 2011-06-15 Helmholtz Zentrum Muenchen Spezifische proteaseinhibitoren und ihre verwendung in der krebstherapie
EP2142570B1 (en) * 2007-04-04 2011-06-15 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Anti-epcam antibody and uses thereof
US9689028B2 (en) 2008-12-22 2017-06-27 University Of Utah Foundation Monochrome multiplex quantitative PCR
AU2010295172B2 (en) * 2009-09-21 2016-08-04 Ranju Ralhan Methods and compositions for the diagnosis and treatment of thyroid cancer
TWI485161B (zh) * 2012-03-02 2015-05-21 中央研究院 抗上皮細胞黏著分子（ＥｐＣＡＭ）抗體及其使用方法
CN103387989B (zh) * 2012-09-24 2016-05-18 厦门大学 上皮细胞粘附分子的核酸适体EpCAM D及其制备方法
EP2999800B1 (en) 2013-05-22 2019-09-25 Telomere Diagnostics Inc. Measures of short telomere abundance
CN103275226B (zh) * 2013-06-09 2017-08-29 中国科学技术大学 特异性抗人上皮细胞粘附分子（EpCAM）的单克隆抗体的制备、鉴定及应用
ES3012974T3 (en) * 2014-01-08 2025-04-10 Univ Leland Stanford Junior Targeted therapy for lung cancer
US9944978B2 (en) 2014-12-30 2018-04-17 Telomere Diagnostics, Inc. Multiplex quantitative PCR
ES2873846T5 (en) * 2015-11-19 2025-06-23 Revitope Ltd Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells
US20190262397A1 (en) 2016-07-26 2019-08-29 Tessa Therapeutics Pte. Ltd. Chimeric antigen receptor
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853697A (en) * 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
BRPI9809391B8 (pt) * 1997-04-14 2021-05-25 Amgen Res Munich Gmbh processo para a produção de um receptor de antígeno anti-humano, anticorpo humano e composição farmacêutica
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
US7605238B2 (en) * 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
PT1383785E (pt) * 2001-05-03 2011-06-28 Merck Patent Gmbh Anticorpo recombinante específico de tumores e utilização deste
US20030175268A1 (en) * 2002-01-11 2003-09-18 Saint-Remy Jean-Marie R. Method and pharmaceutical composition for preventing and/or treating systemic inflammatory response syndrome
WO2003099205A2 (en) * 2002-05-20 2003-12-04 Abgenix, Inc. Treatment of renal carcinoma using antibodies against the egfr

Also Published As

Publication number Publication date
CN1976951A (zh) 2007-06-06
WO2005080428A3 (en) 2005-11-10
JP5220315B2 (ja) 2013-06-26
ES2328159T3 (es) 2009-11-10
EA011951B1 (ru) 2009-06-30
EP2107071A3 (en) 2009-12-30
KR20070009988A (ko) 2007-01-19
EP1713830B1 (en) 2009-07-22
EA200601386A1 (ru) 2007-06-29
ATE437186T1 (de) 2009-08-15
HK1096103A1 (en) 2007-05-25
UA87128C2 (ru) 2009-06-25
NO339364B1 (no) 2016-12-05
SI1713830T1 (sl) 2009-10-31
EP1713830A2 (en) 2006-10-25
KR101236224B1 (ko) 2013-02-22
BRPI0507660A (pt) 2007-07-17
CA2555694A1 (en) 2005-09-01
AU2005215874B2 (en) 2011-01-27
WO2005080428A2 (en) 2005-09-01
CA2555694C (en) 2013-04-16
NO20064136L (no) 2006-11-07
DK1713830T3 (da) 2009-10-12
AU2005215874A1 (en) 2005-09-01
PT1713830E (pt) 2009-10-19
US20120294873A1 (en) 2012-11-22
ZA200606083B (en) 2007-10-31
PL1713830T3 (pl) 2010-01-29
JP2008500277A (ja) 2008-01-10
IL177069A0 (en) 2006-12-10
CN1976951B (zh) 2012-03-14
EP2107071A2 (en) 2009-10-07
US20070274982A1 (en) 2007-11-29
NZ549125A (en) 2008-09-26
IL177069A (en) 2010-11-30
US20050180979A1 (en) 2005-08-18
DE602005015544D1 (de) 2009-09-03

Similar Documents

Publication Publication Date Title
US20120294873A1 (en) ANTI-EpCAM IMMUNOGLOBULINS
Ströhlein et al. Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial
KR20220133243A (ko) 항 tigit 길항제 항체를 이용한 암의 치료 방법
WO1994022478A1 (en) PREVENTION OF TUMORS WITH MONOCLONAL ANTIBODIES AGAINST $i(NEU)
US6733752B1 (en) Prevention of tumors with monoclonal antibodies against neu
CN112584872A (zh) 抗组织因子抗体-药物偶联物及其在癌症治疗中的用途
CN112292151B (zh) 抗pd-1抗体在制备治疗实体瘤的药物中的用途
KR20230093282A (ko) 폐암에 대한 lag-3 길항제 요법
CN111315397A (zh) 治疗肿瘤的方法
CN117202934A (zh) 抗pd-1抗体联合一线化疗治疗晚期非小细胞肺癌的用途
WO2022122765A2 (en) Antibody and taxane combination therapy
CN115364209A (zh) 抗pd-1抗体联合化疗治疗食管癌的用途
HK1096103B (en) Anti-epcam immunoglobulins
WO2025088496A1 (en) Combination of antibody-drug conjugate and anti-pd-1/tim-3 bispecific binding protein
TW202523693A (zh) 手術前後基於抗ｐｄ－１之治療
TW202515614A (zh) 治療非小細胞肺癌之方法及組成物
TW202432585A (zh) 癌症新輔助治療的組合物及方法
CN116209466A (zh) 抗pd-1抗体在治疗鼻咽癌中的用途
CN120583961A (zh) 使用至少结合egfr的抗体及免疫检查点抑制剂组合治疗癌症
HK40109234A (zh) 用於治疗癌症的方法和组合物
CN119731209A (zh) 治疗去势抗性前列腺癌的手段和方法
HK40057287A (en) Intralesional administration of pd-1 inhibitors for treating skin cancer
HK40057287B (en) Intralesional administration of pd-1 inhibitors for treating skin cancer
HK40002353A (en) Methods of treating skin cancer by administering a pd-1 inhibitor

Legal Events

Date Code Title Description
FG Grant or registration
HH Correction or change in general
HC Change of company name or juridical status